Semi-Annual 3D Bioprinting Core Symposium: A Half-Year of Successful Activity
Friday, October 21, 2016
9:00am – 1:00pm
Walther Hall R3, Room 303
980 W. Walnut Street
Indianapolis, IN 46202
9:00am - 11:00am - Opening Remarks and 6 presenters (R3, Conference Room 303)
11:00am - 11:30am - General Discussion (R3, Conference Room 303)
11:30am - 1:00pm - Poster Session and light refreshments (R3, foyer on the 2nd floor)
1:00pm - 2:30pm - Core Open House in its new location (R3, Room C343)
We invite you to the first-Annual Symposium of the 3D Bioprinting Core at IU School of Medicine/IUPUI, which will feature the Regenova Bio 3D Printer by Cyfuse Biomedical. Scaffold-free 3D bioprinting is the latest - and one of the most promising - developments in automated tissue engineering.
Bioprinting is a branch of additive bio-manufacturing, seeking to create three-dimensional constructs for repair or replacement of damaged tissues. Bioprinting was developed traditionally as a biological version of 3D printing, which is the scaffold-dependent layer-by-layer deposition of cell loaded media known as ‘bio-inks’ or ‘scaffolds’ that incorporate biomaterials. Progress is particularly relevant for the musculoskeletal system, representing relatively larger constructs made from a few cell types, naturally compatible with a dense extracellular matrix (such as bone or cartilage). However, for small-scale cell-heterogeneous tissues, where the direct inter-cellular interaction is crucial at every step of tissue development, the presence of scaffolds limits cell-cell interaction, therefore interfering with vital tissue development cascades. Alternatively, ‘scaffold-free’ bioprinting methods, such as that accomplished by The Regenova, can now allow the design and culture of tissue constructs composed of masses of cells held in their desired form by the cells’ secreted matrix. Affectionately named ‘Regina’ by the Core’s team, The Regenova is the first scaffold-free bioprinting robot installed in an academic institution in the US.
The University has taken the lead in this dynamic field of tissue engineering by securing access to both scaffold-dependent and scaffold-free bioprinters. It is therefore important to assemble users and potential collaborators to showcase the recent developments made with bioprinting and to discuss its ever-expanding potential. Some colleagues, who embraced and became early users of this new technology, will present their progress, challenges, and plans for continued use of the bioprinter in podium and poster presentations. The goal of this symposium is to inform and inspire a community of participants who contribute to the development of the University as a bioprinting leader.
Poster Abstract Submission
Anyone interested in presenting a poster at the Symposium should submit an abstract by October 11, 2016. Confirmation of whether or not the poster will be included at the event will be sent by October 14, 2016.
Abstract header should include: Title of Abstract, Authors, Author Affiliations. Abstracts are limited to 500 words. PDFs or Word documents are acceptable.
Questions about the symposium can be directed to Dr. Nicanor Moldovan at email@example.com.
This symposium was made possible, in part, with support from the Indiana Clinical and Translational Sciences Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.